Advertisement

Aids-Related Non-Hodgkin Lymphomas

Molecular Genetics, Viral Infection, and Cytokine Deregulation
  • Gianluca Gaidano
  • Cristina Pastore
  • Annunziata Gloghini
  • Daniela Capello
  • Gisella Volpe
  • Paolo Ghia
  • Giuseppe Saglio
  • Antonino Carbone

Abstract

AIDS-related non-Hodgkin lymphomas (AIDS-NHL) are almost invariably derived from B cells and are grouped into three distinct histologic categories, including small non cleaved cell lymphoma (SNCCL), diffuse large cell lymphoma (DLCL), and anaplastic large cell lymphoma (ALCL). In addition, AIDS-NHL presenting solely as a body cavity effusion are thought to be a peculiar clinico-pathologic entity and are defined as body-cavity-based lymphoma (BCBL). At the biologic level, AIDS-related lymphomagenesis is characterized by activation of proto-oncogenes, inactivation of tumor suppressor genes, viral infection of the tumor clone, and deregulated cytokine production. Distinct AIDS-NHL types associate with specific molecular pathways. The first pathogenetic pathway clusters with AIDS-SNCCL, and is characterized by a relatively mild degree of host immunodeficiency. AIDS-SNCCL consistently associates with c-MYC rearrangements and p53 inactivation in 100% and 60% of the cases respectively, whereas infection by Epstein-Barr virus (EBV) is restricted to 30% of the cases. Production of high levels of IL-10 is an additional peculiar feature of EBV positive AIDS-SNCCL. The second pathogenetic pathway associates with AIDS-DLCL, which is usually accompanied by a marked immunodeficiency of the host. AIDS-DLCL is characterized by EBV infection in the large majority of cases and by the mutually exclusive presence of BCL-6 rearrangements and c-MYC translocation in 40% of the cases. A third pathway characterizes AIDS-BCBL, which associates virtually in all cases with infection by EBV and with the presence of DNA sequence of the recently identified Kaposi sarcoma herpes virus (KSHV) in the apparent absence of other known genetic lesions. Finally, the pathogenetic features of AIDS-ALCL are still under investigation.

Keywords

Anaplastic Large Cell Lymphoma Genetic Lesion Diffuse Large Cell Lymphoma Chronic Antigen Stimulation Persistent Generalize Lymphadenopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    . Karp JE, Broder S: Acquired immunodeficiency syndrome and non-Hodgkin’s lymphomas. Cancer Res 51: 4743, 1991PubMedGoogle Scholar
  2. 2.
    . Beral V, Peterman T, Berkelman R, Jaffe H: AIDS-associated non-Hodgkin lymphomas. Lancet 337: 805, 1991PubMedCrossRefGoogle Scholar
  3. 3.
    . Levine AM: Acquired immunodeficiency syndrome-related lymphoma. Blood 80: 8, 1992PubMedGoogle Scholar
  4. 4.
    . Gaidano G, Carbone A: AIDS-related lymphomas: From pathogenesis to pathology. Br J Haematol, 90: 235, 1995PubMedCrossRefGoogle Scholar
  5. 5.
    . Walts AE, Shintaku IP, Said JW: Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. Am J Clin Pathol 94: 170, 1990PubMedGoogle Scholar
  6. 6.
    . Green I, Espiritu E, Ladanyi M, Chaponda R, Wieczorek R, Gallo L, Feiner H: Primary lymphomatous effusions in AIDS: a morphologic, immunophenotypic and molecular study. Mod Pathol 8: 39, 1995PubMedGoogle Scholar
  7. 7.
    . Pluda JM, Venzon D, Tosato G, Lietzau J, Wywill K, Nelson DL, Jaffe ES, Karp JE, Broder S, Yarchoan R: Parameters affecting the development of non-Hodgkin’s lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 11: 1099, 1993PubMedGoogle Scholar
  8. 8.
    . Gaidano G, Dalla-Favera R: Molecular pathogenesis of AIDS-related lymphomas. Adv Cancer Res, 67: 113, 1995PubMedCrossRefGoogle Scholar
  9. 9.
    . Frizzera G: Atypical lymphoproliferative disorders. In Neoplastic Hematopathology. DM Knowles, ed. Baltimore: Williams & Wilkins, pp. 459–495. 1992Google Scholar
  10. 10.
    . Birx DL, Redfield RR, Tosato G: Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 314: 874, 1986PubMedCrossRefGoogle Scholar
  11. 11.
    . Pelicci PG, Knowles DM, Arlin ZA, Wieczorek R, Luciw P, Dina D, Basilico C, Dalla-Favera R: Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 164: 2049, 1986PubMedCrossRefGoogle Scholar
  12. 12.
    . Riboldi P, Gaidano G, Schettino EW, Knowles DM, Dalla-Favera R, Casali P: Two AIDS-associated Burkitt’s lymphomas produce specific anti-i IgM cold agglutinins utilizing somatically mutated VH4-21 segments. Blood 83: 2952, 1994PubMedGoogle Scholar
  13. 13.
    . Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Blood 81: 166, 1993PubMedGoogle Scholar
  14. 14.
    . Gaidano G, Parsa NZ, Tassi V, Della-Latta P, Chaganti RSK, Knowles DM, Dalla-Favera R: In vitro establishment of AIDS-related lymphoma cell lines: Phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection. Leukemia 7: 1621, 1993PubMedGoogle Scholar
  15. 15.
    . Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM: CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72: 3078, 1993PubMedCrossRefGoogle Scholar
  16. 16.
    . Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186, 1995PubMedCrossRefGoogle Scholar
  17. 17.
    . Gaidano G, Dalla-Favera R: Molecular biology of lymphoid neoplasms. In The Molecular Basis of Cancer. Mendelsohn J, Howley PM, Israel MA, Liotta LA, eds. Philadelphia: WB Saunders, pp. 251–279. 1995Google Scholar
  18. 18.
    . Bhatia K, Spangler G, Gaidano G, Hamdy N, Dalla-Favera R, Magrath I: Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 84: 883, 1994PubMedGoogle Scholar
  19. 19.
    . Lombardi L, Newcomb EW, Dalla-Favera R: Pathogenesis of Burkitt’s lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human lymphoblasts. Cell 49: 161, 1987PubMedCrossRefGoogle Scholar
  20. 20.
    . Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533, 1985PubMedCrossRefGoogle Scholar
  21. 21.
    . Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R: Rearrangements of the BCL-6 gene in AIDS-associated non-Hodgkin’s lymphoma: Association with diffuse large cell subtype. Blood 84: 397, 1994PubMedGoogle Scholar
  22. 22.
    . Gaidano G, Hauptschein RS, Parsa NZ, Offit K, Rao PH, Lenoir G, Knowles DM, Chaganti RSK, Dalla-Favera R: Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma. Blood 80: 1781, 1992PubMedGoogle Scholar
  23. 23.
    . Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M: Human immunodeficiency-virus-associated lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 11: 1674, 1993PubMedGoogle Scholar
  24. 24.
    . Carbone A, Gloghini A, Zanette I, Canal B, Volpe R: Demonstration of Epstein-Barr virus genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas. Am J Clin Pathol 99: 289, 1993PubMedGoogle Scholar
  25. 25.
    . Carbone A, Gloghini A, Volpe R, Boiocchi M, Tirelli, and the Italian Cooperative Group on AIDS and Tumors: High frequency of Epstein-Barr virus latent membrane protein-1 expression in AIDS-related Ki-1 (CD30)-positive anaplastic large cell lymphomas. Am J Clin Pathol 101: 768, 1994PubMedGoogle Scholar
  26. 26.
    . Shibata M, Weiss LM, Nathwani BN, Brynes KK, Levine AM: Epstein-Barr virus in benigh lymphnode biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin’s lymphoma. Blood 77: 1527, 1991PubMedGoogle Scholar
  27. 27.
    . Contreras-Bodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG: B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: Studies with somatic cell hybrids. J Gen Virol 72: 3025, 1991CrossRefGoogle Scholar
  28. 28.
    . Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865, 1994PubMedCrossRefGoogle Scholar
  29. 29.
    . Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G: Immunopathogenetic mechanisms in human immunodeficiency virus (HIV) infection. Ann Int Med 114: 678, 1991PubMedGoogle Scholar
  30. 30.
    . Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, Michelis JF, Van Damme J, Taga T, Kishimoto T, Crevon MC, Galanaud P: Interleukin-6 production in high grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-negative patients. Blood 80: 498, 1992PubMedGoogle Scholar
  31. 31.
    . Callard R, Gearing A: The Cytokine Factsbook. London: Academic Press, 1994Google Scholar
  32. 32.
    . Benjamin D, Knobloch TJ, Dayton MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt’s lymphoma constitutively secrete large quantities of interleukin-10. Blood 80: 1289, 1992PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Gianluca Gaidano
    • 1
    • 5
  • Cristina Pastore
    • 1
  • Annunziata Gloghini
    • 2
  • Daniela Capello
    • 1
  • Gisella Volpe
    • 1
  • Paolo Ghia
    • 3
  • Giuseppe Saglio
    • 1
    • 4
  • Antonino Carbone
    • 2
  1. 1.Laboratorio di Medicina e Oncologia Molecolare Dipartimento di Scienze Biomediche e Oncologia Umana Ospedale San LuigiUniversità di TorinoTorinoItaly
  2. 2.Divisione di Anatomia PatologicaI.R.C.C.S.-Centro di Riferimento OncologicoAvianoItaly
  3. 3.Basel Institute for ImmunologyBaselSwitzerland
  4. 4.CNR-CIOSUniversità di TorinoTorinoItaly
  5. 5.Laboratorio di Medicina e Oncologia Molecolare, Sezione 5A, Dipartimento di Scienze Biomediche e Oncologia Umana, Ospedale San LuigiUniversità di TorinoOrbassano - TorinoItaly

Personalised recommendations